Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21 Academic Article uri icon

Overview

MeSH Major

  • Adjuvants, Immunologic
  • Breast Neoplasms
  • Cancer Vaccines
  • Saponins

abstract

  • Immunization with sTn(c)-KLH conjugate plus QS-21 is well tolerated and immunogenic in high-risk breast cancer patients. Future trials will incorporate sTn(c) as a component of a multiple antigen vaccine.

publication date

  • May 15, 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-06-2189

PubMed ID

  • 17504999

Additional Document Info

start page

  • 2977

end page

  • 85

volume

  • 13

number

  • 10